BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/22/2022 4:46:09 AM | Browse: 560 | Download: 1246
 |
Received |
|
2021-08-07 16:29 |
|
Peer-Review Started |
|
2021-08-07 16:33 |
|
First Decision by Editorial Office Director |
|
2021-11-11 09:09 |
|
Return for Revision |
|
2021-11-11 09:09 |
|
Revised |
|
2021-11-22 18:26 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-02-22 03:28 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-02-23 21:11 |
|
Articles in Press |
|
2022-02-23 21:11 |
|
Edit the Manuscript by Language Editor |
|
2022-02-21 04:56 |
|
Typeset the Manuscript |
|
2022-03-21 01:53 |
|
Publish the Manuscript Online |
|
2022-03-22 04:46 |
| ISSN |
2220-3249 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pharmacology & Pharmacy |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Therapeutic potential of N-acetyl cysteine during COVID-19 epoch
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ajita Kapur, Munish Sharma and Geetanjali Sageena |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Geetanjali Sageena, PhD, Assistant Professor, Environmental Studies, Keshav Mahavidyalaya University of Delhi, H-4-5 Zone Pitampura, New Delhi 110034, India. geetanjali.sageena@keshav.du.ac.in |
| Key Words |
N-acetyl cysteine; COVID-19; Coagulopathy; Therapeutic potential |
| Core Tip |
Risk of coagulopathy is noteworthy in coronavirus disease 2019 (COVID-19) and cerebral haemorrhage could be a potential risk in COVID-19 patients receiving N-acetyl cysteine (NAC). Results of well-designed randomized controlled trials should be awaited before NAC becomes a common practice for prophylaxis and treatment of patients with COVID-19. |
| Publish Date |
2022-03-22 04:46 |
| Citation |
Kapur A, Sharma M, Sageena G. Therapeutic potential of N-acetyl cysteine during COVID-19 epoch. World J Virol 2022; 11(2): 104-106 |
| URL |
https://www.wjgnet.com/2220-3249/full/v11/i2/104.htm |
| DOI |
https://dx.doi.org/10.5501/wjv.v11.i2.104 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
